Why COVID sufferers in the US can’t get ensitrelvir, the antiviral drug better than Paxlovid
Medicine By Marc Lallanilla Published October 26, 2023, 3:45 p.m. ET For people suffering from a COVID-19 attack, the antiviral Paxlovid has been a godsend. The drug became the go-to antiviral treatment during the pandemic after the Food and Drug Administration granted it emergency use authorization in December 2021. Now… Continue Reading Why COVID sufferers in the US can’t get ensitrelvir, the antiviral drug better than Paxlovid